189952-45-2

Basic information

• Product Name: 2-Piperidinecarboxylicacid,4-hydroxy-,methylester,trans-(9CI)
• Synonyms: 2-Piperidinecarboxylicacid,4-hydroxy-,methylester,trans-(9CI);2-Piperidinecarboxylic acid, 4-hydroxy-, Methyl ester, (2R,4R)-rel-;trans-methyl-4-hydroxypiperidine-2-carboxylate
• CAS NO: 189952-45-2
• Molecular Formula: C7H13NO3
• Molecular Weight: 159.18
• Product Categories: CARBOXYLICESTER
• Mol File: 189952-45-2.mol
• Article Data: 15

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-Piperidinecarboxylicacid,4-hydroxy-,methylester,trans-(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Piperidinecarboxylicacid,4-hydroxy-,methylester,trans-(9CI)(189952-45-2)
• EPA Substance Registry System: 2-Piperidinecarboxylicacid,4-hydroxy-,methylester,trans-(9CI)(189952-45-2)

Safety Data

• Hazardous Substances Data: 189952-45-2(Hazardous Substances Data)

Upstream product

• 67-56-1 methanol 
• 127-17-3 2-oxo-propionic acid 
• 177944-16-0 (R)-N-(but-3-en-1-yl)-N-(α-methylbenzyl)amine 
• 5162-44-7 1-bromo-4-butene 
• 298-12-4 Glyoxilic acid 
• 114963-47-2 N-(3-butenyl)-N-[(S)-1-phenylethyl]amine 
• 1799811-83-8 1-(tert-butyl)-2-methyl-(S)-4-oxopiperidine-1,2-dicarboxylate 
• 1103929-31-2 methyl 4(S)-hydroxy-1-[1(R)-phenylethyl]piperidine-2(S)-carboxylate 
• 847029-99-6 1-benzyl 2-methyl 4-hydroxypiperidine-1,2-dicarboxylate 
• 1103929-42-5 methyl 4(R)-hydroxy-1-[1(R)-phenylethyl]piperidine-2(R)-carboxylate 
• 225656-39-3 1-(9-fluorenylmethyl) 2-methyl (2R,4R)-4-formyloxy-1,2-piperidinedicarboxylate 
• 1212688-40-8 (2S,4R)-1-(tert-butoxycarbonyl)-4-hydroxypiperidine-2-carboxylic acid 
• 403503-37-7 (2S,4R)-1-benzyl 2-methyl 4-hydroxypiperidine-1,2-dicarboxylate 
• 198646-60-5 (S)-1-(tertbutyloxycarbonyl)-4-oxo-piperidine-2-carboxylic acid 

Downstream Products

• 321744-26-7 N-Boc-4-hydroxy-2-piperidine carboxylic acid methyl ester 
• 254882-06-9 (2S,4R)-methyl 1-(tert-butoxycarbonyl)-4-hydroxypiperidine-2-carboxylate 
• 4382-31-4 (2S,4S)-4-hydroxy-2-piperidinecarboxylic acid 
• 1844-40-2 (2S,4R)-4-hydroxypiperidine-2-carboxylic acid 
• 1448668-04-9 (2S,4R)-methyl 1-(2,2-diphenylacetyl)-4-hydroxypiperidine-2-carboxylate 
• 1448668-26-5 C₃₀H₂₈FNO₄ 
• 1448667-65-9 (2S,4S)-4-(benzyloxy)-1-(2,2-diphenylacetyl)piperidine-2-carboxylic acid 
• 1448667-66-0 (2S,4R)-4-(benzyloxy)-1-(2,2-diphenylacetyl)piperidine-2-carboxylic acid 
• 1448668-05-0 C₂₈H₂₉NO₄ 
• 1448668-18-5 C₃₀H₂₉NO₄ 
• 1432130-53-4 C₁₆H₂₃NO₆S 
• 1432130-57-8 C₂₃H₂₉NO₈S₂ 
• 1432130-61-4 C₂₂H₂₉NO₇S₂ 
• 81357-18-8 4-oxo-piperidine-1,2-dicarboxylic acid 1-tert-butyl ester 2-methyl ester 

Relevant articles and documents

CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE

Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with the enzyme ceramide galactosyltransferase (CGT), such as, for example, lysosomal storage diseases. Examples of lysosomal storage diseases include, for example, Krabbe disease and Metachromatic Leukodystrophy.

HETEROCYCLE DERIVATIVE HAVING PGD2 RECEPTOR ANTAGONIST ACTIVITY

The present invention is related to a compound represented by formula (I), wherein X1, X2, X3, X4, X5, R5, R6, R7, R8, n, p, q, ring A and ring B are as described in the specification, or a

The discovery of CCR3/H1 dual antagonists with reduced hERG risk

A series of dual CCR3/H1 antagonists based on a bispiperidine scaffold were discovered. Introduction of an acidic group overcame hERG liability. Bioavailability was optimised by modulation of physico-chemical properties and physical form to del